Pediatric Perfusion Products Market Analysis

  • Report ID: 2686
  • Published Date: Oct 06, 2025
  • Report Format: PDF, PPT

Pediatric Perfusion Products Market Segmentation:

End user Segment Analysis

Pediatric cardiac centers are dominating the end user segment and is expected to hold the revenue share of 45.0% by 2035. The segment is driven by their expertise in treating congenital heart conditions. Such facilities need sophisticated perfusion systems designed to pediatric physiology. The Health Children data in July 2023 states that more than 1,800 pediatric organ transplants occur every year, most of which involve perfusion support. Increasing volumes in surgery and growth of specialized care centers are fueling demand for high-performance perfusion products, making this segment a prime revenue driver in 2035.

Product Type Segment Analysis

Based on the product type, the pediatric perfusion pumps segment is predicted to capture the largest share at 33% in the pediatric perfusion products market over the assessed period. The growth of the pediatric perfusion pump segment is expected to continue increasing due to the rising rates of congenital heart disease and advancements in pump technology, which enhance patient safety. Pediatric perfusion pumps are essential during cardiac surgeries, enabling surgeons to precisely control blood flow for extremely fragile pediatric patients. In addition to that, the market will be supported by hospitals that are upgrading their existing pumps to improved pediatric-specific pumps that do not have the traditional risk of complications associated with extracorporeal circulation.

Technology Segment Analysis  

In terms of technology, the disposable pediatric perfusion sets segment is anticipated to hold the highest revenue proportion in the pediatric perfusion products market throughout the discussed timeline. As per the NLM study in December 2022, the disposable component usage is 86% in centers. The move toward disposable perfusion sets is driven by imperatives for infection control and regulatory guidelines for single-use devices in order to help reduce hospital-acquired infections. The World Health Organization (WHO) is focusing on the use of disposables to reduce the risk of contaminating sensitive pediatric populations. Disposables also provide operational efficiencies and lower sterilization costs. This is prompting higher adoption rates around the globe.

Our in-depth analysis of the pediatric perfusion products market includes the following segments: 

Segment

Subsegment

Product Type

  • Oxygenators
  • Pumps
  • Heat Exchangers
  • Cannulae
  • Tubing
  • Monitoring Systems

Technology

  • Cardiopulmonary Bypass (CPB)
  • Pediatric Cardiac Centers
  • Children’s Hospitals
  • Research Institutions
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Pediatric Cardiac Centers
  • Children’s Hospitals
  • Research Institutions
  • Ventricular Assist Devices (VADs)
  • Pediatric Cardiac Centers
  • Children’s Hospitals
  • Research Institutions
  • Biopreservation Techniques
  • Pediatric Cardiac Centers
  • Children’s Hospitals
  • Research Institutions

Application

  • Cardiac Surgery
  • Oxygenators
  • Pumps
  • Heat Exchangers
  • Cannulae
  • Tubing
  • Monitoring Systems
  • Respiratory Failure
  • Oxygenators
  • Pumps
  • Heat Exchangers
  • Cannulae
  • Tubing
  • Monitoring Systems
  • Organ Transplantation
  • Oxygenators
  • Pumps
  • Heat Exchangers
  • Cannulae
  • Tubing
  • Monitoring Systems
  • Congenital Hear Defect Treatment
  • Oxygenators
  • Pumps
  • Heat Exchangers
  • Cannulae
  • Tubing
  • Monitoring Systems

End user

  • Pediatric Cardiac Centers
  • Children’s Hospitals
  • Research Institutions

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of pediatric perfusion products is evaluated at USD 640.5 million.

Pediatric Perfusion Products Market size was valued at USD 640.5 million in 2025 and is projected to reach USD 1136.1 million by the end of 2035, rising at a CAGR of 5.9% during the forecast period, i.e., 2026-2035

The North America industry is predicted to account for the largest share of 36% by 2035, owing to the robust healthcare infrastructure and high volume of surgical procedures in the region.

The major players in the market are BioPerfusion Australia Pty Ltd, Seoul Medical Technologies, Indian HeartTech Pvt. Ltd., Malaysian CardioMed Solutions, CardioTech USA, MedEuropa Pharma AG, Innovate Perfusion Systems Ltd., Tokyo MedCare Corporation, BioCardia Solutions GmbH, HeartCare Technologies Inc., Asia MedTech Pvt Ltd, Pacific Perfusion Systems, K-Cardio Solutions, EuroPharma Medica, NewAge MedSystems Ltd., Tokyo Biomed Co., Ltd., MedAsia Healthcare
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos